ZA989011B - Indanol compounds a process for their preparation and pharmaceutical compositions containing them - Google Patents

Indanol compounds a process for their preparation and pharmaceutical compositions containing them

Info

Publication number
ZA989011B
ZA989011B ZA989011A ZA989011A ZA989011B ZA 989011 B ZA989011 B ZA 989011B ZA 989011 A ZA989011 A ZA 989011A ZA 989011 A ZA989011 A ZA 989011A ZA 989011 B ZA989011 B ZA 989011B
Authority
ZA
South Africa
Prior art keywords
alkyl
alkoxy
atoms
indanol
preparation
Prior art date
Application number
ZA989011A
Other languages
English (en)
Inventor
Jean-Louis Peglion
Bertrand Goument
Mark Millan
Andrian Newman-Tancredi
Anne Dekeyne
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of ZA989011B publication Critical patent/ZA989011B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/18Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted otherwise than in position 3 or 7
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/101,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/141,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/161,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18Ethylenedioxybenzenes, not substituted on the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
ZA989011A 1997-10-03 1998-10-02 Indanol compounds a process for their preparation and pharmaceutical compositions containing them ZA989011B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9712336A FR2769312B1 (fr) 1997-10-03 1997-10-03 Nouveaux composes de l'indanol, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
ZA989011B true ZA989011B (en) 1999-04-12

Family

ID=9511782

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA989011A ZA989011B (en) 1997-10-03 1998-10-02 Indanol compounds a process for their preparation and pharmaceutical compositions containing them

Country Status (19)

Country Link
US (2) US5958927A (zh)
EP (1) EP0906912B1 (zh)
JP (1) JP3884177B2 (zh)
CN (1) CN1122666C (zh)
AT (1) ATE230739T1 (zh)
AU (1) AU736710B2 (zh)
BR (1) BR9804485A (zh)
CA (1) CA2249756C (zh)
DE (1) DE69810560T2 (zh)
DK (1) DK0906912T3 (zh)
ES (1) ES2190574T3 (zh)
FR (1) FR2769312B1 (zh)
HK (1) HK1019736A1 (zh)
HU (1) HUP9802194A1 (zh)
NO (1) NO316693B1 (zh)
NZ (1) NZ332142A (zh)
PL (1) PL191091B1 (zh)
PT (1) PT906912E (zh)
ZA (1) ZA989011B (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2769312B1 (fr) * 1997-10-03 1999-12-03 Adir Nouveaux composes de l'indanol, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP0982304B1 (en) * 1998-06-30 2002-10-02 Eli Lilly And Company Piperidine derivatives having effects on serotonin related systems
US6197798B1 (en) 1998-07-21 2001-03-06 Novartis Ag Amino-benzocycloalkane derivatives
ES2240420T3 (es) * 2000-01-18 2005-10-16 Novartis Ag Carboxamidas utiles como inhibidores de la proteina de transferencia de trigliceridos microsomicos y de la secrecion de apolipoproteina b.
US20020077278A1 (en) * 2000-06-05 2002-06-20 Yong V. Wee Use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders
US7504395B2 (en) * 2001-07-20 2009-03-17 Psychogenics, Inc. Treatment for attention-deficit hyperactivity disorder
DE10142662B4 (de) * 2001-08-31 2004-07-08 Aventis Pharma Deutschland Gmbh Derivate von C2-substituierten Indan-1-ol-Systemen und ihre Verwendung als Arzneimittel
DE10142661B4 (de) 2001-08-31 2004-06-09 Aventis Pharma Deutschland Gmbh Mehrfach substituierte Indan-1-ol-Systeme und ihre Verwendung als Arzneimittel
DE10142667B4 (de) * 2001-08-31 2004-06-09 Aventis Pharma Deutschland Gmbh C2-substituierte Indan-1-ole und ihre Derivate und ihre Verwendung als Arzneimittel
FR2883876B1 (fr) * 2005-03-30 2007-05-04 Servier Lab Derives d'indanyl-piperazines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0185429A1 (en) * 1984-12-21 1986-06-25 Duphar International Research B.V New bicyclic heteroaryl piperazines
AU6548286A (en) * 1985-10-04 1987-04-24 Maggioni-Winthrop S.P.A. Fused cycloaliphatic aminoalcohols
FR2670491B1 (fr) * 1990-12-14 1993-02-05 Adir Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les renfermant.
FR2692264B1 (fr) * 1992-06-12 1994-08-05 Adir Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant.
FR2734819B1 (fr) * 1995-05-31 1997-07-04 Adir Nouveaux composes de la piperazine, de la piperidine et de la 1,2,5,6-tetrahydropyridine, leur procede de preparation et les compositions pharmaceutiques les contenant
FR2769312B1 (fr) * 1997-10-03 1999-12-03 Adir Nouveaux composes de l'indanol, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
NO984620L (no) 1999-04-06
FR2769312A1 (fr) 1999-04-09
JPH11158179A (ja) 1999-06-15
CA2249756C (fr) 2003-12-02
AU8787598A (en) 1999-04-22
JP3884177B2 (ja) 2007-02-21
PL328989A1 (en) 1999-04-12
DK0906912T3 (da) 2003-04-22
ATE230739T1 (de) 2003-01-15
FR2769312B1 (fr) 1999-12-03
BR9804485A (pt) 2000-04-11
HUP9802194A1 (hu) 1999-12-28
NO984620D0 (no) 1998-10-02
PL191091B1 (pl) 2006-03-31
DE69810560D1 (de) 2003-02-13
HU9802194D0 (en) 1998-11-30
AU736710B2 (en) 2001-08-02
CA2249756A1 (fr) 1999-04-03
EP0906912A1 (fr) 1999-04-07
HK1019736A1 (en) 2000-02-25
NO316693B1 (no) 2004-03-26
ES2190574T3 (es) 2003-08-01
DE69810560T2 (de) 2003-11-27
CN1218051A (zh) 1999-06-02
EP0906912B1 (fr) 2003-01-08
PT906912E (pt) 2003-04-30
CN1122666C (zh) 2003-10-01
US5958927A (en) 1999-09-28
US6060487A (en) 2000-05-09
NZ332142A (en) 2000-05-26

Similar Documents

Publication Publication Date Title
GR3031492T3 (en) 1,4-Disubstituted piperazines for the treatment of disorders of the central nervous system and neuro-endocrine disorders
ZA989011B (en) Indanol compounds a process for their preparation and pharmaceutical compositions containing them
NZ331613A (en) Piperazinyl or piperidinyl substituted 1,2,3,4-tetrahydronaphthalene derivatives
ZA89389B (en) Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia
IL103595A0 (en) 2-heterocyclicethylamine derivatives,their preparation and pharmaceutical compositions containing them
HK1017685A1 (en) New heterocyclic compounds, a process for their preparation and pharmaceutical compositions containing them
HU895648D0 (en) Process for the preparation of n,n-disubstituted diaryl-alkancarboxylic acid amide derivatives and pharmaceutical compositions containing such compounds
DE60005525D1 (de) 2-aminotetraline zur behandlung von glaukom
GB2117771B (en) Enantiomers of substituted phenylazacycloalkanes
FR2695643B1 (fr) Dérivés d'uréido-acétamide, leur préparation et les médicaments les contenant.
MX9707839A (es) Derivado de acetamida, procesos para la preparacion del mismo, y composiciones farmaceuticas que contienen el mismo.